Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Wright

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Trials|October 18, 2018
The clinical and cost effectiveness of adapted dialectical behaviour therapy (DBT) for bipolar mood instability in primary care (ThrIVe-B programme): a feasibility studyKim Wright, Alyson Dodd, Fiona C Warren, et al.
BMJ Open|June 1, 2023
Off-pump injectable versus on-pump conventional tissue valves for pulmonary valve replacement: the injectable valve implantation randomised trial (INVITE)Rachael Heys, Terrie Walker-Smith, Rebecca Evans, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2013
1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonistsAndrew M K Pennell, James B Aggen, Subhabrata Sen, et al.
International Journal of Bipolar Disorders|July 22, 2023
The IBER study: a feasibility randomised controlled trial of imagery based emotion regulation for the treatment of anxiety in bipolar disorderCraig Steel, Kim Wright, Guy M Goodwin, et al.
Eclinicalmedicine|August 2, 2023
Preliminary clinical and cost effectiveness of augmented depression therapy versus cognitive behavioural therapy for the treatment of anhedonic depression (ADepT): a single-centre, open-label, parallel-group, pilot, randomised, controlled trialBarnaby D Dunn, Emily Widnall, Laura Warbrick, et al.
International Journal of Bipolar Disorders|July 1, 2021
Psychological therapy for mood instability within bipolar spectrum disorder: a randomised, controlled feasibility trial of a dialectical behaviour therapy-informed approach (the ThrIVe-B programme)Kim Wright, Alyson L Dodd, Fiona C Warren, et al.
Behaviour Research and Therapy|November 13, 2022
How well do Cognitive Behavioural Therapy and Behavioural Activation for depression repair anhedonia? A secondary analysis of the COBRA randomized controlled trialBatool Alsayednasser, Emily Widnall, Heather O'Mahen, et al.
Pilot and Feasibility Studies|May 8, 2019
Evaluating Augmented Depression Therapy (ADepT): study protocol for a pilot randomised controlled trialBarnaby D Dunn, Emily Widnall, Nigel Reed, et al.
The Journal of Experimental Medicine|August 31, 2006
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor developmentJennifer M Burns, Bretton C Summers, Yu Wang, et al.
Bipolar Disorders|April 18, 2024
Psychological therapies for people with bipolar disorder: Where are we now, and what is next? ISBD Psychological Interventions Taskforce-Position paperKim Wright, Manja Koenders, Katie M Douglas, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Trials|October 18, 2018
The clinical and cost effectiveness of adapted dialectical behaviour therapy (DBT) for bipolar mood instability in primary care (ThrIVe-B programme): a feasibility studyKim Wright, Alyson Dodd, Fiona C Warren, et al.
BMJ Open|June 1, 2023
Off-pump injectable versus on-pump conventional tissue valves for pulmonary valve replacement: the injectable valve implantation randomised trial (INVITE)Rachael Heys, Terrie Walker-Smith, Rebecca Evans, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2013
1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonistsAndrew M K Pennell, James B Aggen, Subhabrata Sen, et al.
International Journal of Bipolar Disorders|July 22, 2023
The IBER study: a feasibility randomised controlled trial of imagery based emotion regulation for the treatment of anxiety in bipolar disorderCraig Steel, Kim Wright, Guy M Goodwin, et al.
Eclinicalmedicine|August 2, 2023
Preliminary clinical and cost effectiveness of augmented depression therapy versus cognitive behavioural therapy for the treatment of anhedonic depression (ADepT): a single-centre, open-label, parallel-group, pilot, randomised, controlled trialBarnaby D Dunn, Emily Widnall, Laura Warbrick, et al.
International Journal of Bipolar Disorders|July 1, 2021
Psychological therapy for mood instability within bipolar spectrum disorder: a randomised, controlled feasibility trial of a dialectical behaviour therapy-informed approach (the ThrIVe-B programme)Kim Wright, Alyson L Dodd, Fiona C Warren, et al.
Behaviour Research and Therapy|November 13, 2022
How well do Cognitive Behavioural Therapy and Behavioural Activation for depression repair anhedonia? A secondary analysis of the COBRA randomized controlled trialBatool Alsayednasser, Emily Widnall, Heather O'Mahen, et al.
Pilot and Feasibility Studies|May 8, 2019
Evaluating Augmented Depression Therapy (ADepT): study protocol for a pilot randomised controlled trialBarnaby D Dunn, Emily Widnall, Nigel Reed, et al.
The Journal of Experimental Medicine|August 31, 2006
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor developmentJennifer M Burns, Bretton C Summers, Yu Wang, et al.
Bipolar Disorders|April 18, 2024
Psychological therapies for people with bipolar disorder: Where are we now, and what is next? ISBD Psychological Interventions Taskforce-Position paperKim Wright, Manja Koenders, Katie M Douglas, et al.
Pageof 5